Showing results (231-240 of 258) with videos related to

Sort By:
Pageof 26
Journal of Clinical Microbiology|March 25, 2011
Investigating transmission of Mycobacterium bovis in the United Kingdom in 2005 to 2008Sema Mandal, Louise Bradshaw, Laura F Anderson, et al.
Oncotarget|April 13, 2016
The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistanceKevin S Quackenbush, Stacey Bagby, Wai Meng Tai, et al.
Cancer Prevention Research (Philadelphia, Pa.)|June 4, 2011
Oral iloprost improves endobronchial dysplasia in former smokersRobert L Keith, Patrick J Blatchford, John Kittelson, et al.
Shock (Augusta, Ga.)|July 1, 2014
Age-related differences in biomarkers of acute inflammation during hospitalization for sepsisAdit A Ginde, Patrick J Blatchford, Stephen Trzeciak, et al.
European Journal of Heart Failure|April 11, 2023
The win ratio method in heart failure trials: lessons learnt from EMPULSEStuart J Pocock, João Pedro Ferreira, Timothy J Collier, et al.
Circulation|April 4, 2022
Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE TrialMikhail N Kosiborod, Christiane E Angermann, Sean P Collins, et al.
Clinical Cardiology|August 27, 2016
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrillation Who Have Undergone Percutaneous Coronary Intervention With StentingChristopher P Cannon, Savion Gropper, Deepak L Bhatt, et al.
Oncotarget|January 18, 2018
The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapyJustin Greene, Anna Nguyen, Stacey M Bagby, et al.
European Journal of Heart Failure|July 9, 2024
Time from admission to randomization and the effect of empagliflozin in acute heart failure: A post-hoc analysis from EMPULSEJoão Pedro Ferreira, Jonathan P Blatchford, John R Teerlink, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2018
Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck CancerSana D Karam, Krishna Reddy, Patrick J Blatchford, et al.
Pageof 26